10mon MSN
Both of these stocks seem too cheap to ignore. The post 2 ASX value shares for 2025 appeared first on The Motley Fool ...
The sell-off has opened the window for value plays to shine. The post ASX value shares rated as broker buys appeared first on ...
ASX shudders; environment watchdog blocks Contact wind project; spot gold tops $US3000; Woolworths upgraded; New Hope rallies ...
Here are three top ASX stocks that could be great buys for investors with $7,000 to invest this month. Here's what analysts ...
This ASX 200 share could be dirt cheap according to one leading broker. Let's see what it is saying after recent ...
16h
Market Index News on MSNEvening Wrap: ASX 200 gains as coal stocks pop on strong NHC result, copper miners rally, NAB and MQG hit hardCoal stocks popped on a well received half-year results release from New Hope Corporation (NHC) (+8.9%) and uranium stocks ...
Australia’s sharemarket erased most of its gains during the afternoon’s session following tensions out of the Middle East ...
Shares close higher; China consumption rises, property prices hit; MinRes rallies; two bidders court Smartpay, leaps 49pc; ...
It hasn't been the best quarter for Macmahon Holdings Limited (ASX:MAH) shareholders, since the share price has fallen 23% in ...
The Australian sharemarket posts cautious gains after Wall Street’s rollercoaster ride sent US stocks higher overnight.
It might be of some concern to shareholders to see the Vysarn Limited (ASX:VYS) share price down 11% in the last month. But over five years returns have been remarkably great. Indeed, the share price ...
4h
Stockhead on MSNBiocurious: FDA approval remains the Holy Grail for ASX life science stocksDespite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results